Viva Biotech Holdings (VB0) - Total Liabilities

Latest as of June 2025: €2.98 Billion EUR ≈ $3.48 Billion USD

Based on the latest financial reports, Viva Biotech Holdings (VB0) has total liabilities worth €2.98 Billion EUR (≈ $3.48 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Viva Biotech Holdings cash flow conversion to assess how effectively this company generates cash.

Viva Biotech Holdings - Total Liabilities Trend (2016–2024)

This chart illustrates how Viva Biotech Holdings's total liabilities have evolved over time, based on quarterly financial data. Check VB0 financial resilience to evaluate the company's liquid asset resilience ratio.

Viva Biotech Holdings Competitors by Total Liabilities

The table below lists competitors of Viva Biotech Holdings ranked by their total liabilities.

Company	Country	Total Liabilities
Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd SHG:605069	China	CN¥2.27 Billion
Fujian Oriental Silver Star Investment Co Ltd SHG:600753	China	CN¥260.46 Million
Hana Tour KO:039130	Korea	₩490.41 Billion
Shyft Group Inc NASDAQ:SHYF	USA	$333.76 Million
First Business Financial Services NASDAQ:FBIZ	USA	$3.71 Billion
Sweco AB (publ) ST:SWEC-A	Sweden	Skr17.47 Billion
Nanjing Res In of Surveying Mapping SHE:300826	China	CN¥1.16 Billion
Guangzhou Tech-Long Packing Machine Co Ltd SHE:002209	China	CN¥2.47 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Viva Biotech Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Viva Biotech Holdings worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.76	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Viva Biotech Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Viva Biotech Holdings (2016–2024)

The table below shows the annual total liabilities of Viva Biotech Holdings from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€3.23 Billion ≈ $3.78 Billion	-14.03%
2023-12-31	€3.76 Billion ≈ $4.40 Billion	-12.84%
2022-12-31	€4.32 Billion ≈ $5.05 Billion	+4.47%
2021-12-31	€4.13 Billion ≈ $4.83 Billion	-6.05%
2020-12-31	€4.40 Billion ≈ $5.14 Billion	+3522.38%
2019-12-31	€121.39 Million ≈ $141.92 Million	-56.32%
2018-12-31	€277.90 Million ≈ $324.89 Million	+459.82%
2017-12-31	€49.64 Million ≈ $58.03 Million	+96.06%
2016-12-31	€25.32 Million ≈ $29.60 Million	--

About Viva Biotech Holdings

F:VB0 Germany Biotechnology

Market Cap

$439.02 Million

€375.52 Million EUR

Market Cap Rank

#13226 Global

#1365 in Germany

Share Price

€0.18

Change (1 day)

+0.56%

52-Week Range

€0.15 - €0.34

All Time High

€1.18